newheader.jpg
 


Click here to download

About The Pharmaceutical Strategy Series
The Pharmaceutical Strategy Series produces executive-level conferences that bring together R&D leaders and corporate executives to assess business opportunities, enhance corporate value, and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries.

PSS conferences are uniquely designed to maximize peer-to-peer networking and idea sharing. Conference topics are chosen based on attendee feedback and advice given by the PSS Advisory Board, which is comprised of decision-makers at most of the world's leading pharmaceutical companies. Presentations in each Executive Conference will give you the ideas, information, and resources you need to make faster and smarter decisions.

The Pharmaceutical Strategy Series is a division of Cambridge Healthtech Institute.




Second Annual 
Global R&D Congress

Strategic Planning for Discovery, Development and Clinical Operations in China, India and other Emerging Regions
May 29-30, 2008 • The Ritz-Carlton • Washington, D.C.
Program | Register | Download


Effective Alliance Management
June 4-5, 2008 • Philadelphia, PA
Program | Register | Download Brochure


Managing Projects & Resources
June 5-6, 2008 • Philadelphia, PA
Program | Register | Download Brochure


Third Annual
Drug Development China
Strategies for Launching Discovery and Development Activities
September 16-18, 2008 • The Fairmont • San Francisco, CA
Program | Register


Third Annual
Post-Approval Drug Safety Strategies
Best Practices to Assess and Mitigate Risks throughout the Product’s Life Cycle
November 12-14, 2008 • Ritz-Carlton, Pentagon City • Arlington, VA
Program | Register


Sixth Annual
Strategic Resource Management
November 17-18, 2008 • Hyatt Regency at Penn’s Landing • Philadelphia, PA
Program | Register


Third Annual
Portfolio Management
November 18-19, 2008 • Hyatt Regency at Penn’s Landing • Philadelphia, PA
Program | Register


The role of the Advisory Board is to assist CHI in identifying those issues which are seminal to decision-making in today's challenging world of drug development with the expressed intention of creating a forum for dialogue, constructive debate, and shared learning within the industry."

Richard M. Bayney, Ph.D., 
Vice President, Decision Analysis & Portfolio Management, PRD,
Johnson & Johnson


For partnering and sponsorship information, please contact:

Arnie Wolfson
Manager, Business Development
Pharmaceutical Strategy Series
Cambridge Healthtech Institute
T: 781.972.5431
E: awolfson@healthtech.com


Other Series:
Proteomics
, Drug Development, Informatics, Genomics, Chemistry, Diagnostic

Richard M. Bayney, Ph.D.
Vice President, Decision Analysis and Portfolio, Management, PRD
Johnson & Johnson

Balu Balasubramanian, Ph.D.,
Executive Director, Research and Development, Bristol-Myers Squibb Co.

Matt Bell, Ph.D., MA
Senior Director, Discovery Research Strategy, Wyeth

Dennis Engers
International Director, Preclinical Planning and Resource Management, sanofi-aventis

Rainer Fuchs, Ph.D.
Co-Head Discovery Research
Vice President, Research Informatics,
Biogen Idec Inc.

Richard Heaslip, Ph.D.
Vice President, Project and Portfolio Management, Wyeth

Shama Kajiji, Ph.D., MBA
Director, Portfolio Franchise Management Department, Merck & Co.

Sundeep Lal, Ph.D., MBA
Senior Director, New Products Licensing, Global Human Health,
Merck & Co.

Michael Liebman, Ph.D.
Chief Scientific Officer,
Windber Research Institute

Jann Nielsen, Ph.D.
Director, Project Management,
Wyeth Research

James Resch, Ph.D.
Director, Strategic Planning, Global Discovery Affairs, AstraZeneca

Jill Robinson, R.Ph., MBA
Vice President, Global Safety Surveillance & Epidemiology, Wyeth

Kim Slocum
Director, Strategic Planning & Business Development, AstraZeneca LP

Sean Zhao, Ph.D.
Director, Pharmacovigilance and Global Safety, Amgen Inc.

Partnership Programs

PSS Founding Partners

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com